• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴结和骨髓中恶性淋巴瘤的比较组织学

Comparative histology of malignant lymphomas in lymph node and bone marrow.

作者信息

Bartl R, Hansmann M L, Frisch B, Burkhardt R

机构信息

Abt. f. Knochenmarksdiagnostik, Medizinische Klinik Innenstadt d.Universität, München.

出版信息

Br J Haematol. 1988 Jun;69(2):229-37. doi: 10.1111/j.1365-2141.1988.tb07627.x.

DOI:10.1111/j.1365-2141.1988.tb07627.x
PMID:3291929
Abstract

Lymph node and bone marrow biopsies of 226 patients with malignant lymphomas were available for evaluation and comparison. 120 of the 226 lymphoma patients had classifiable infiltration in both lymph node and bone marrow and these were used for comparison. Congruence in the histologic subtypes in lymph node and bone marrow was found in 91 patients (76%). The majority of the 29 cases with divergent histologies showed ML of low grade malignancy in the bone marrow even with long time intervals between the two biopsies. The most notable in this group were seven cases who had ML centroblastic/centrocytic in the lymph node biopsy and ML immunocytic in the bone marrow, although none had a serum M-component. 65 of the 106 patients excluded from comparison had involvement in only one organ, the others had unclassifiable or equivocal histologies in either lymph node or bone marrow or in both. The findings are discussed with respect to the histologic behaviour of the lymphomas. The results show that comparison between lymph node and bone marrow findings in patients with ML is feasible and clinically relevant.

摘要

对226例恶性淋巴瘤患者的淋巴结和骨髓活检样本进行了评估和比较。226例淋巴瘤患者中,有120例在淋巴结和骨髓中均有可分类的浸润,这些样本用于比较。91例患者(76%)的淋巴结和骨髓组织学亚型一致。29例组织学不同的病例中,大多数即使在两次活检间隔时间较长的情况下,骨髓中仍显示为低级别恶性淋巴瘤。该组中最值得注意的是7例患者,其淋巴结活检显示为中心母细胞/中心细胞性淋巴瘤,而骨髓活检显示为免疫细胞性淋巴瘤,尽管均无血清M成分。被排除在比较之外的106例患者中,65例仅累及一个器官,其他患者在淋巴结或骨髓或两者中具有不可分类或不明确的组织学表现。针对淋巴瘤的组织学行为对这些发现进行了讨论。结果表明,对淋巴瘤患者的淋巴结和骨髓检查结果进行比较是可行的,且具有临床相关性。

相似文献

1
Comparative histology of malignant lymphomas in lymph node and bone marrow.淋巴结和骨髓中恶性淋巴瘤的比较组织学
Br J Haematol. 1988 Jun;69(2):229-37. doi: 10.1111/j.1365-2141.1988.tb07627.x.
2
Discordant morphologic characteristics of B-cell lymphomas in bone marrow and lymph node biopsies.骨髓和淋巴结活检中B细胞淋巴瘤不一致的形态学特征。
Am J Clin Pathol. 1990 Jul;94(1):59-66. doi: 10.1093/ajcp/94.1.59.
3
Assessment of bone marrow histology in the malignant lymphomas (non-Hodgkin's): correlation with clinical factors for diagnosis, prognosis, classification and staging.
Br J Haematol. 1982 Aug;51(4):511-30. doi: 10.1111/j.1365-2141.1982.tb02815.x.
4
[Centroblastic and centrocytic centroblastic malignant lymphomas, predominantly splenic (or primary of the spleen). Anatomo-clinical study of 17 cases].[中心母细胞性和中心细胞性中心母细胞性恶性淋巴瘤,主要累及脾脏(或脾脏原发性)。17例病例的解剖学-临床研究]
Bull Cancer. 1987;74(4):437-53.
5
Incidence and histological features of bone marrow involvement in malignant lymphomas.恶性淋巴瘤骨髓受累的发病率及组织学特征
Ann Hematol. 1992 Aug;65(2):61-5. doi: 10.1007/BF01698130.
6
Involvement of the bone marrow by non-Hodgkin's lymphomas: incidence, histology and pathologic correlations.非霍奇金淋巴瘤累及骨髓:发病率、组织学及病理相关性
Tumori. 1981 May-Jun;67(3):191-6. doi: 10.1177/030089168106700305.
7
Terminal deoxynucleotidyl transferase in diagnosis of lymphomas.
Folia Haematol Int Mag Klin Morphol Blutforsch. 1989;116(2):245-50.
8
Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.非霍奇金淋巴瘤的骨髓受累:淋巴结与骨髓形态学不一致的临床意义。内布拉斯加淋巴瘤研究组
J Clin Oncol. 1990 Jul;8(7):1163-72. doi: 10.1200/JCO.1990.8.7.1163.
9
Histological transformation of non-Hodgkin's lymphoma: a prospective study.非霍奇金淋巴瘤的组织学转化:一项前瞻性研究。
Cancer. 1979 Aug;44(2):645-51. doi: 10.1002/1097-0142(197908)44:2<645::aid-cncr2820440234>3.0.co;2-y.
10
Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.采用荧光原位杂交技术对B细胞慢性淋巴细胞白血病患者外周血、骨髓和淋巴结中的12号三体进行评估。
Haematologica. 1999 Mar;84(3):212-7.

引用本文的文献

1
Nodular pattern of bone marrow infiltration: frequent finding in immunosuppression-related EBV-associated large B-cell lymphomas.骨髓浸润的结节模式:与免疫抑制相关的 EBV 相关的大 B 细胞淋巴瘤中的常见表现。
Virchows Arch. 2009 Oct;455(4):323-36. doi: 10.1007/s00428-009-0837-4. Epub 2009 Oct 6.
2
Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma--a practical guideline.骨髓活检中的局灶性淋巴样聚集(结节):良性增生与恶性淋巴瘤的鉴别——实用指南
J Clin Pathol. 1999 Apr;52(4):294-300. doi: 10.1136/jcp.52.4.294.
3
Bone marrow trephine biopsy in lymphoproliferative disease.
淋巴增殖性疾病中的骨髓环钻活检
J Clin Pathol. 1993 Apr;46(4):380-1. doi: 10.1136/jcp.46.4.380-c.
4
Treatment and survival of lymphoid malignancy in the north-west of England: a population-based study.英格兰西北部淋巴恶性肿瘤的治疗与生存情况:一项基于人群的研究。
Br J Cancer. 1995 Sep;72(3):757-65. doi: 10.1038/bjc.1995.406.
5
Malignant lymphoma of the gastrointestinal tract and mesentery. A clinico-pathologic study of the significance of histologic classification. NHL Study Group of the Comprehensive Cancer Center West.胃肠道和肠系膜恶性淋巴瘤。关于组织学分类意义的临床病理研究。西部综合癌症中心非霍奇金淋巴瘤研究组
Am J Pathol. 1989 Aug;135(2):281-9.
6
Reticulin fibre content of bone marrow infiltrates of malignant non-Hodgkin's lymphomas (B-cell type, low malignancy)--a morphometric evaluation before and after therapy.
Virchows Arch A Pathol Anat Histopathol. 1990;417(6):485-92. doi: 10.1007/BF01625728.
7
Bone marrow trephine biopsy in lymphoproliferative disease.
J Clin Pathol. 1992 Sep;45(9):745-50. doi: 10.1136/jcp.45.9.745.
8
Incidence and histological features of bone marrow involvement in malignant lymphomas.恶性淋巴瘤骨髓受累的发病率及组织学特征
Ann Hematol. 1992 Aug;65(2):61-5. doi: 10.1007/BF01698130.